ZA963210B - Inhibiting photodecomposition of 3-substituted-2-oxindoles. - Google Patents

Inhibiting photodecomposition of 3-substituted-2-oxindoles.

Info

Publication number
ZA963210B
ZA963210B ZA9603210A ZA963210A ZA963210B ZA 963210 B ZA963210 B ZA 963210B ZA 9603210 A ZA9603210 A ZA 9603210A ZA 963210 A ZA963210 A ZA 963210A ZA 963210 B ZA963210 B ZA 963210B
Authority
ZA
South Africa
Prior art keywords
oxindoles
substituted
photodecomposition
inhibiting
inhibiting photodecomposition
Prior art date
Application number
ZA9603210A
Other languages
English (en)
Inventor
Jr Willard C Newlin
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA963210B publication Critical patent/ZA963210B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polymerisation Methods In General (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9603210A 1995-04-24 1996-04-23 Inhibiting photodecomposition of 3-substituted-2-oxindoles. ZA963210B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
ZA963210B true ZA963210B (en) 1997-10-23

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9603210A ZA963210B (en) 1995-04-24 1996-04-23 Inhibiting photodecomposition of 3-substituted-2-oxindoles.

Country Status (30)

Country Link
EP (1) EP0827399A1 (sv)
JP (1) JPH10506635A (sv)
KR (1) KR100189585B1 (sv)
CN (1) CN1053667C (sv)
AP (1) AP607A (sv)
AR (1) AR002728A1 (sv)
AU (1) AU692378B2 (sv)
BG (1) BG100531A (sv)
BR (1) BR9602024A (sv)
CO (1) CO4700418A1 (sv)
FI (1) FI973988A (sv)
HR (1) HRP960194A2 (sv)
HU (1) HU216544B (sv)
IL (1) IL117969A0 (sv)
IS (1) IS4339A (sv)
MA (1) MA23848A1 (sv)
NO (1) NO961622L (sv)
NZ (1) NZ286432A (sv)
OA (1) OA10286A (sv)
PE (1) PE34397A1 (sv)
RO (1) RO113305B1 (sv)
RU (1) RU2109510C1 (sv)
SG (1) SG64924A1 (sv)
SI (1) SI9600133A (sv)
SK (1) SK51296A3 (sv)
TR (1) TR199600300A2 (sv)
UA (1) UA42739C2 (sv)
WO (1) WO1996033701A1 (sv)
YU (1) YU25096A (sv)
ZA (1) ZA963210B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019132959A1 (en) 2017-12-29 2019-07-04 Kraft Foods Group Brands Llc Improved oxidative stability of oil-in-water emulsions using natural stabilizers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
AP9600787A0 (en) 1996-04-30
YU25096A (sh) 1998-08-14
JPH10506635A (ja) 1998-06-30
SI9600133A (en) 1996-10-31
AP607A (en) 1997-08-27
WO1996033701A1 (en) 1996-10-31
BG100531A (en) 1997-06-30
SK51296A3 (en) 1997-04-09
RU2109510C1 (ru) 1998-04-27
CN1053667C (zh) 2000-06-21
MA23848A1 (fr) 1996-12-31
TR199600300A2 (tr) 1996-11-21
HUP9601057A2 (en) 1997-04-28
FI973988A0 (sv) 1997-10-17
HRP960194A2 (en) 1998-02-28
HU216544B (hu) 1999-07-28
AU692378B2 (en) 1998-06-04
CO4700418A1 (es) 1998-12-29
EP0827399A1 (en) 1998-03-11
NO961622D0 (no) 1996-04-23
IS4339A (is) 1996-10-25
IL117969A0 (en) 1996-08-04
PE34397A1 (es) 1997-09-29
FI973988A (sv) 1997-10-17
KR960037656A (ko) 1996-11-19
RO113305B1 (ro) 1998-06-30
AU5085196A (en) 1996-11-07
NZ286432A (en) 1998-05-27
SG64924A1 (en) 1999-05-25
OA10286A (en) 1997-09-19
KR100189585B1 (ko) 1999-06-01
CN1139110A (zh) 1997-01-01
HU9601057D0 (en) 1996-06-28
UA42739C2 (uk) 2001-11-15
NO961622L (no) 1996-10-25
HUP9601057A3 (en) 1997-05-28
BR9602024A (pt) 1998-10-06
AR002728A1 (es) 1998-04-29

Similar Documents

Publication Publication Date Title
ZA9610858B (en) Heteroclyclic compounds.
ZA967315B (en) Biphenylamides.
ZA968957B (en) Process for the preparation of dihaloazolopyrimidines.
ZA961444B (en) Pyrazolylbenzoyl derivatives.
MX213417B (es) Fenilpiridazinonas.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA965505B (en) Novel compounds.
ZA961955B (en) Indazolecarboxamides.
ZA961449B (en) Isoxazolylbenzoyl derivatives.
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
ZA966711B (en) Chemical synthesis.
HK1009747A1 (en) New cryptophycins from synthesis.
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA965922B (en) Preparation of N-substituted 3-hydroxypyrazoles.
ZA967741B (en) Diarylalkenylamine derivatives.
ZA964682B (en) Methods of inhibiting melanoma.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA966399B (en) Endothelin-receptor-antagonists.
ZA964560B (en) Anit-viral compounds.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
ZA966452B (en) Process for the preparation of substituted aminocarbonyltriazolinones.
ZA966750B (en) Halogenobenzimidazoles.
ZA966933B (en) Endothelin-receptor-antagonists.
ZA9610589B (en) Pharmaceutical compounds.